ResearcherZhongshan HospitalNo recent work listed

Xiaocui Li

ORCID-verified (high confidence)As of 10 November 2026

Matched on ORCID iD 0000-0003-3391-9980; OpenAlex author ID A5100723330.

Their work

Papers: 2 (first author 1, last author 0)
Trials: 0
Grants: 0
Collaborators: 3

Papers, trials and grants by year

2020: 1 paper · 2021: none · 2022: 1 paper

Papers 2

CCL2-mediated monocytes regulate immune checkpoint blockade resistance in pancreatic cancer. First author DOI 10.1016/j.intimp.2022.108598 ↗
Inactivation of Pancreatic Stellate Cells by Exendin-4 Inhibits the Migration and Invasion of Pancreatic Cancer Cells. Co-author DOI 10.2147/ott.s259853 ↗

Closest collaborators

The 3 strongest of 3 ranked by shared papers, trials and grants, with recent and small-team work weighing most.

Meizhu Yan · 2 shared papers, 2020–2022
- Paper CCL2-mediated monocytes regulate immune checkpoint blockade resistance in pancreatic cancer. DOI 10.1016/j.intimp.2022.108598 ↗
- Paper Inactivation of Pancreatic Stellate Cells by Exendin-4 Inhibits the Migration and Invasion of Pancreatic Cancer Cells. DOI 10.2147/ott.s259853 ↗
Zhenjun Gao · 2 shared papers, 2020–2022
- Paper CCL2-mediated monocytes regulate immune checkpoint blockade resistance in pancreatic cancer. DOI 10.1016/j.intimp.2022.108598 ↗
- Paper Inactivation of Pancreatic Stellate Cells by Exendin-4 Inhibits the Migration and Invasion of Pancreatic Cancer Cells. DOI 10.2147/ott.s259853 ↗
Xin Meng · 1 shared paper, 2020
- Paper Inactivation of Pancreatic Stellate Cells by Exendin-4 Inhibits the Migration and Invasion of Pancreatic Cancer Cells. DOI 10.2147/ott.s259853 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.